Clinical trial · Interventional
Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC
NCT03870269CI-TRIAL-00080278completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs, provide surgeons with an improved understanding of their patients' anatomy, resulting in more efficient operations (robotic prostatectomy) and improved patient care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ceevra Reveal | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention Arm
- description
- Subjects whose surgeon will be viewing VR models in addition to the source CT/MR image in connection with the case.
- interventionNames
- Device: Ceevra Reveal
- type
- NO_INTERVENTION
- label
- Control Arm
- description
- Subjects whose surgeon will only be viewing CT/MR images in connection with the case.
Primary outcomes (1)
- measure
- Total operative time
- timeFrame
- During procedure, not to exceed 12 hours
Secondary outcomes (11)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Patient is undergoing robotic prostatectomy being performed by participating surgeon * Patient is willing to be randomized between intervention and control arms Exclusion Criteria: * Patients with prior pelvic radiation * Patients with prior androgen deprivation therapy * Patients with prior localized ablative therapy * Patients with prior TURP or other surgical BPH treatment
References
Publications (0)
Data not yet available
No reference posted for this study.